Women's Malignancies Branch

Chief
Stanley Lipkowitz, M.D., Ph.D.
Deputy Chief
Patricia S. Steeg, Ph.D.

The Women's Malignancies Branch (WMB) conducts basic, translational and clinical research on the mechanisms of cancer with emphasis on those that only or primarily affect females such as breast and ovarian cancer. Research in the laboratories of the Branch covers subjects including growth factor receptor signaling, cell survival and the induction of apoptosis, metastasis, and DNA repair and cell cycle check points. The research links basic and translational experimental cancer biology and clinical investigation.

Our clinical research translates the laboratory and pre-clinical research findings into novel mechanism-based, hypothesis driven clinical trials for patients with these diseases aimed at improving outcomes for patients and informing future laboratory and clinical efforts. The WMB provides Intramural researchers collaborative opportunities to translate their findings into clinical trials. The WMB trains scientists in laboratory and translational research; and trains medical and gynecologic oncology fellows toward development of expertise supporting their subspecialty board certification.

Position Contact Name Contact E-mail Contact Phone Research Area Keywords Number of Positions
Postdoctoral Fellow Jung-Min Lee leej6@mail.nih.gov 301-443-7735

DNA repair, cell cycle pathways, BRCA mutation

1
Patient Care Coordinator III Lauri Rimorin lauri.rimorin@nih.gov

clinical patient coordination, clinical trials, data management 

1

About

The Women's Malignancies Branch (WMB) conducts basic, translational and clinical research on the mechanisms of cancer with emphasis on those that only or primarily affect females such as breast and ovarian cancer. Research in the laboratories of the Branch covers subjects including growth factor receptor signaling, cell survival and the induction of apoptosis, metastasis, and DNA repair and cell cycle check points. The research links basic and translational experimental cancer biology and clinical investigation.

Our clinical research translates the laboratory and pre-clinical research findings into novel mechanism-based, hypothesis driven clinical trials for patients with these diseases aimed at improving outcomes for patients and informing future laboratory and clinical efforts. The WMB provides Intramural researchers collaborative opportunities to translate their findings into clinical trials. The WMB trains scientists in laboratory and translational research; and trains medical and gynecologic oncology fellows toward development of expertise supporting their subspecialty board certification.

Clinical Trials

PI & Key Staff

Positions

Position Contact Name Contact E-mail Contact Phone Research Area Keywords Number of Positions
Postdoctoral Fellow Jung-Min Lee leej6@mail.nih.gov 301-443-7735

DNA repair, cell cycle pathways, BRCA mutation

1
Patient Care Coordinator III Lauri Rimorin lauri.rimorin@nih.gov

clinical patient coordination, clinical trials, data management 

1

Contact Info

Women's Malignancies Branch
Center for Cancer Research
National Cancer Institute
Building 10, Room 4B54
Bethesda, MD 20892-1361
Ph: 240-858-3281
Fax: 240-541-4547
Secretary
240-858-3281
Secretary (Contr.)
240-858-3007